Luo, Peng
Zhujiang Hospital · Kangda College of Nanjing Medical University · Southern Medical University
20 papers on CoChatORCID 0000-0002-8215-2045
Most cited papers
- Verified
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
Hay, S. I., Ong, K. L., Santomauro, D. F., A, B., Aalipour, M. A., Aalruz, H., Ababneh, H. S., Abaraogu, U. O., Abate, B. B., Abbafati, C., et al. (2025) · The Lancet
Global Health and EpidemiologyCardiovascular Health and Risk Factors
Cited by 916
- Verified
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer
Lin, A., Zhang, J., & Luo, P. (2020) · Frontiers in Immunology
Cancer Immunotherapy and BiomarkersGenetic factors in colorectal cancer
Cited by 358
- Verified
Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
Zhou, C., Peng, S., Lin, A., Jiang, A., Peng, Y., Gu, T., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2023) · eClinicalMedicine
Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions
Cited by 213
- Verified
CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer
Lin, A., Qi, C., Wei, T., Li, M., Cheng, Q., Liu, Z., Luo, P., & Zhang, J. (2022) · Briefings in Bioinformatics
Cancer Immunotherapy and BiomarkersBioinformatics and Genomic Networks
Cited by 152
- Verified
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023
Haeuser, E., Byrne, S., Nguyen, J., Raggi, C., McLaughlin, S. A., Bisignano, C., Harris, A. A., Smith, A. E., Lindstedt, P. A., Smith, G., et al. (2025) · The Lancet
Vaccine Coverage and HesitancyGlobal Maternal and Child Health
Cited by 143
- Verified
Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Gao, Z., Bai, Y., Lin, A., Jiang, A., Zhou, C., Cheng, Q., Liu, Z., Chen, X., Zhang, J., & Luo, P. (2023) · Molecular Cancer
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 138
- Verified
The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy
Shi, C., Qin, K., Lin, A., Jiang, A., Cheng, Q., Liu, Z., Zhang, J., & Luo, P. (2022) · Journal of Experimental & Clinical Cancer Research
Cancer Immunotherapy and BiomarkersDNA Repair Mechanisms
Cited by 85
- Verified
HPVTIMER: A shiny web application for tumor immune estimation in human papillomavirus‐associated cancers
Liu, L., Xie, Y., Yang, H., Lin, A., Dong, M., Wang, H., Zhang, C., Liu, Z., Cheng, Q., Zhang, J., et al. (2023) · iMeta
Cancer Immunotherapy and BiomarkersCervical Cancer and HPV Research
Cited by 62
- Verified
DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer
Li, M., Lin, A., Luo, P., Shen, W., Xiao, D., Gou, L., Zhang, J., & Guo, L. (2020) · Aging
Lung Cancer Research StudiesLung Cancer Treatments and Mutations
Cited by 62
- Verified
ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment
Yi, R., Lin, A., Cao, M., Xu, A., Luo, P., & Zhang, J. (2020) · Frontiers in Genetics
Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments
Cited by 60
- Verified
Heterogeneity of Intratumoral Microbiota Within the Tumor Microenvironment and Relationship to Tumor Development
Gao, Z., Jiang, A., Li, Z., Zhu, L., Mou, W., Shen, W., Luo, P., Tang, B., Zhang, J., & Lin, A. (2025) · Med Research
Gut microbiota and healthBacterial Cancer Therapy
Cited by 51
- Verified
Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors
Lin, A., Huang, L., Jiang, A., Zhu, L., Mou, W., Li, Y., Zhang, C., Liu, Z., Zhang, J., Cheng, Q., et al. (2025) · BMC Medicine
Cancer Immunotherapy and BiomarkersGut microbiota and health
Cited by 46
- Verified
The Evaluation of Generative AI Should Include Repetition to Assess Stability
Zhu, L., Mou, W., Hong, C., Yang, T., Lai, Y., Qi, C., Lin, A., Zhang, J., & Luo, P. (2024) · JMIR mHealth and uHealth
Artificial Intelligence in Healthcare and EducationArtificial Intelligence in Healthcare
Cited by 38
- Verified
MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer
Yi, R., Hong, S., Zhang, Y., Lin, A., Ying, H., Zou, W., Wang, Q., Wei, T., Cheng, Q., Zhu, W., et al. (2022) · Frontiers in Cell and Developmental Biology
Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments
Cited by 37
- Verified
STAGER checklist: Standardized testing and assessment guidelines for evaluating generative artificial intelligence reliability
Chen, J., Zhu, L., Mou, W., Lin, A., Zeng, D., Qi, C., Liu, Z., Jiang, A., Tang, B., Shi, W., et al. (2024) · iMetaOmics
Artificial Intelligence in Healthcare and EducationArtificial Intelligence in Healthcare
Cited by 33
- Verified
TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Lin, A., Zhang, H., Meng, H., Deng, Z., Gu, T., Luo, P., & Zhang, J. (2021) · Frontiers in Immunology
Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations
Cited by 27
- Verified
Assembly and electrocatalytic CO2 reduction of two-dimensional bimetallic porphyrin-based conjugated cobalt metal-organic framework
Li, J., Shen, H., Ma, C., Zhang, H., Luo, P., Chen, J., Mu, M., & Yin, X. (2023) · Electrochimica Acta
CO2 Reduction Techniques and CatalystsElectrocatalysts for Energy Conversion
Cited by 23
- Verified
Emerging Concern of Scientific Fraud: Deep Learning and Image Manipulation
Qi, C., Zhang, J., & Luo, P. (2020) · bioRxiv (Cold Spring Harbor Laboratory)
Academic integrity and plagiarismDigital Media Forensic Detection
Cited by 21
- Verified
Evaluating the potential risks of employing large language models in peer review
Zhu, L., Lai, Y., Xie, J., Mou, W., Huang, L., Qi, C., Yang, T., Jiang, A., Gan, W., Zeng, D., et al. (2025) · Clinical and Translational Discovery
Academic integrity and plagiarismEthics and Social Impacts of AI
Cited by 15
- Verified
Navigating academic integrity in biomedical research: The impact of large language models on current practices and future directions
Lin, A., Chen, Z., Jiang, A., Tang, B., Qi, C., Zhu, L., Mou, W., Gan, W., Zeng, D., Xiao, M., et al. (2026) · International Journal of Surgery
Academic integrity and plagiarismEthics and Social Impacts of AI
Cited by 2
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free